Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, and efficacy of cabozantinib in hepatocellular carcinoma patients with impaired liver function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN